Literature DB >> 7479568

Gastric pH influences the appearance of double peaks in the plasma concentration-time profiles of cimetidine after oral administration in dogs.

V Mummaneni1, G L Amidon, J B Dressman.   

Abstract

The plasma concentration-time profiles of cimetidine often exhibit two peaks following oral administration of a single dose in the fasted state, while the concurrent administration of some antacids results in a lower extent as well as rate of absorption. In the present work, absorption of cimetidine after a single dose in the fasted state was studied as a function of gastric pH in male beagle dogs to determine whether gastric pH plays a role in the double peak phenomenon and/or can account for the decrease in bioavailability when antacids are coadministered. The extent of absorption of cimetidine was not influenced significantly by gastric pH, indicating that elevation of gastric pH is not the cause of decreases in the bioavailability of cimetidine when it is administered with antacids. Distinct double peaks or plateaux were noted in 8 of 10 plasma profiles when the gastric pH was 3 or below. Irregular absorption behavior was observed in 2 of 6 profiles in the pH range of 3 to 5, while single peaks were observed in all 10 profiles when the gastric pH was maintained at pH > or = 5. It was concluded that gastric pH is a major factor in the generation of cimetidine double peaks. Changes in gastric pH also resulted in changes in the apparent kinetics of absorption. Below pH 5, absorption mostly followed zero-order kinetics (9 of 16 profiles) or a more complex kinetic process involving at least two components to the absorption phase (5 of 16 profiles). At gastric pH > or = 5, however, absorption followed first order kinetics in 7 of 10 profiles. These differences in kinetics of absorption are postulated to arise from variations in gastric emptying as a function of pH and/or carryover effects of gastric pH into the upper intestine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479568     DOI: 10.1023/a:1016284214708

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Effect of concomitant antacid administration on plasma cimetidine concentrations during repetitive dosing.

Authors:  D W Shelly; P L Doering; W L Russell; R T Guild; L M Lopez; J Perrin
Journal:  Drug Intell Clin Pharm       Date:  1986-10

2.  Study of the absorption site of cimetidine.

Authors:  N Kaneniwa; T Funaki; S Furuta; N Watari
Journal:  J Pharmacobiodyn       Date:  1986-03

3.  The effect of gastric secretory status on jejunal pH measured by radiotelemetering.

Authors:  J D Maxwell; A Ferguson; W C Watson
Journal:  Digestion       Date:  1971       Impact factor: 3.216

4.  Kinetics of acetaminophen absorption and gastric emptying in man.

Authors:  J A Clements; R C Heading; W S Nimmo; L F Prescott
Journal:  Clin Pharmacol Ther       Date:  1978-10       Impact factor: 6.875

5.  Antacids inhibit absorption of cimetidine.

Authors:  W M Steinberg; J H Lewis; D M Katz
Journal:  N Engl J Med       Date:  1982-08-12       Impact factor: 91.245

6.  Wagner's exact Loo-Riegelman equation: the need for a criterion to choose between the linear and logarithmic trapezoidal rule.

Authors:  J H Proost
Journal:  J Pharm Sci       Date:  1985-07       Impact factor: 3.534

7.  In vitro adsorption studies of cimetidine.

Authors:  F Ganjian; A J Cutie; T Jochsberger
Journal:  J Pharm Sci       Date:  1980-03       Impact factor: 3.534

8.  Penicillamine kinetics in normal subjects.

Authors:  R F Bergstrom; D R Kay; T M Harkcom; J G Wagner
Journal:  Clin Pharmacol Ther       Date:  1981-09       Impact factor: 6.875

9.  Absorption of flurbiprofen in the fed and fasted states.

Authors:  J B Dressman; R R Berardi; G H Elta; T M Gray; P A Montgomery; H S Lau; K L Pelekoudas; G J Szpunar; J G Wagner
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

10.  The slowing of gastric emptying by four strong acids and three weak acids.

Authors:  J N Hunt; M T Knox
Journal:  J Physiol       Date:  1972-04       Impact factor: 5.182

View more
  6 in total

1.  Evidence for dissolution rate-limited absorption of COL-3, a matrix metalloproteinase inhibitor, leading to the irregular absorption profile in rats after oral administration.

Authors:  Jing Li; Hung Huynh; Eli Chan
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

2.  Intestinal uptake of cimetidine and ranitidine in rats.

Authors:  V Mummaneni; J B Dressman
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

3.  Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.

Authors:  Ekarat Jantratid; Sompol Prakongpan; Gordon L Amidon; Jennifer B Dressman
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Appearance of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function.

Authors:  Yukiko Metsugi; Yoshihiro Miyaji; Ken-ichi Ogawara; Kazutaka Higaki; Toshikiro Kimura
Journal:  Pharm Res       Date:  2007-10-23       Impact factor: 4.200

5.  HPLC-MS/MS analysis of a traditional Chinese medical formulation of Bu-Yang-Huan-Wu-Tang and its pharmacokinetics after oral administration to rats.

Authors:  Lee-Hsin Shaw; Lie-Chwen Lin; Tung-Hu Tsai
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

6.  Formulation and Evaluation of Nanocrystals of a Lipid Lowering Agent.

Authors:  Dina Louis
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.